|
Online opportunity for quality, efficiency
With the July acquisition of iKnowMed, an oncology specific electronic medical records (EMR) system, US Oncology found a perfect match. The product has deep and broad oncology content, focuses on the infusion suite that is unique to oncology care, and has the ability to enhance the safety and efficiency of clinical processes. As a web-based product, iKnowMed has the added benefit of being available 24/7 from any location with high-speed Internet connection. iKnowMed is also a proven product that has been actively used by over 130 physicians over the past seven years. The feedback and experience obtained during US Oncology's evaluation of the product were overwhelmingly positive. "Representative comments from physicians and practice staff were that iKnowMed has enabled them to access more and more complete patient data without the need to search and retrieve paper charts, thereby improving efficiency and effectiveness," said Kathy Lokay, vice president of Medical Oncology Decision Support and general manager of iKnowMed. "We also heard that iKnowMed gives practices a greater degree of precision with charge capture and E&M coding documentation. "One practice administrator told us that five months after 'going live,' the system is showing real promise with patient-care management, decision making and safety, which were the main reasons his practice chose the product in the first place." In addition to the software, US Oncology acquired the iKnowMed workforce of 40 highly experienced employees and is now offering iKnowMed exclusively to network members at attractive rates. "We believe from discussions to date that network members will take advantage of this tremendous opportunity to have a consistent clinical information platform that can adapt to changing needs," said Lokay. Reasons iKnowMed is an attractive option include: Implementation and rollout To ease the transition from paper to electronic charts, affiliated practices can choose from two levels of implementation. "Level 1" requires inputting only a limited number of data elements, as well as ordering all chemotherapy, in-house medications and external prescriptions through iKnowMed. Once in the system, nurses can clearly read orders from that day forward and manage the patient's treatment online. In addition, an imbedded dictation and transcription module allows for seamless dictation of encounter notes directly into the patient's electronic chart. "Also standard are interfaces with the Practice Management System for demographic and scheduling information," said Schonherz, "and with the practice's lab information system for real-time viewing and approval of all relevant lab values in the patient's chart." In its fullest capacity, "Level 2" iKnowMed allows physicians to use a combination of "point-and-click" (structured text) and dictation to document the patient encounter. With the structured text method, the note becomes even more thorough as the software guides the user to answer in more detail when possible. This enhanced level of detail enables in-depth reporting and analysis on the practice's clinical information, as well as potential improvements in documentation. Transition to iKnowMed will also be facilitated by a roll-out approach, implementing only a limited number of sites over the next few months. "This will help ensure the product's functionality and speed before a broader roll out," said Lokay. Plans are already under way for iKnowMed to be launched at Rocky Mountain Cancer Centers' Boulder division in mid-November, and for an additional practice site to go online by the end of the year. Beginning in the first quarter of 2005, the pace of implementations will increase significantly. In addition, forums are being established for network-affiliated clinicians' guidance on product development and enhancements. Three user groups comprised of physicians, clinicians and administrators using iKnowMed will meet via conference call on a monthly basis. An Executive Advisory Board will provide financial oversight and prioritize the strategic development of the product. |